A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma.

被引：0
|
作者：
Tsurumi, Hisashi [1 ]
Goto, Naoe [2 ]
Hara, Takeshi [1 ]
Kasahara, Senji [1 ]
Kanemura, Nobuhiro [1 ]
Kitagawa, Junichi [1 ]
Yoshikawa, Takeshi [3 ]
Yamada, Toshiki [1 ]
Sawada, Michio [1 ]
Takahashi, Takeshi [3 ]
Takami, Tsuyoshi [2 ]
Moriwaki, Hisataka [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan
[3] Gifu Municipal Hosp, Div Hematol, Gifu, Japan
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1231 / 1231
页数：1
相关论文
共 50 条
  • [21] Phase II study of bendamustine in combination with rituximab as first-line treatment in patients 80 years or older with aggressive B-cell lymphomas
    Weidmann, E.
    Neumann, A.
    Fauth, F.
    Atmaca, A.
    Al-Batran, S. E.
    Pauligk, C.
    Jaeger, E.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1839 - 1844
  • [22] Panobinostat in Combination with Rituximab in Heavily Pretreated Diffuse Large B-Cell Lymphoma: Results of a Phase II Study
    Barnes, Jeffrey A.
    Redd, Robert Allyn
    Jacobsen, Eric D.
    Fisher, David C.
    Freedman, Arnold S.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Abramson, Jeremy S.
    BLOOD, 2014, 124 (21)
  • [23] Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study
    Barnes, Jeffrey A.
    Redd, Robert
    Fisher, David C.
    Hochberg, Ephraim P.
    Takvorian, Tak
    Neuberg, Donna
    Jacobsen, Eric
    Abramson, Jeremy S.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (04) : 633 - 637
  • [24] A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
    Park, Steven I.
    Richards, Kristy L.
    Asch, Adam S.
    Olajide, Oludamilola
    Deal, Allison M.
    Ivanova, Anastasia
    Wall, James G.
    Sobol, Anna L.
    Foster, Matthew C.
    Muss, Hyman B.
    Shea, Thomas C.
    BLOOD, 2013, 122 (21)
  • [25] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients
    Li, J. M.
    Wang, L.
    Shen, Y.
    Xia, Z. G.
    Chen, Y.
    Chen, Q. S.
    Chen, Y.
    Zeng, X. Y.
    You, J. H.
    Qian, Y.
    Shen, Z. X.
    ANNALS OF HEMATOLOGY, 2007, 86 (09) : 639 - 645
  • [26] Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma
    Niitsu, Nozomi
    Kohri, Mika
    Hagiwara, Yuki
    Tanae, Ken
    Takahashi, Naoki
    Bessho, Masami
    Okamoto, Masataka
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 68 - 74
  • [27] Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients
    J. M. Li
    L. Wang
    Y. Shen
    Z. G. Xia
    Y. Chen
    Q. S. Chen
    Y. Chen
    X. Y. Zeng
    J. H. You
    Y. Qian
    Z. X. Shen
    Annals of Hematology, 2007, 86 : 639 - 645
  • [28] A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
    Morschhauser, Franck
    Feugier, Pierre
    Flinn, Ian W.
    Gasiorowski, Robin
    Greil, Richard
    Illes, Arpad
    Johnson, Nathalie A.
    Larouche, Jean-Francois
    Lugtenburg, Pieternella J.
    Patti, Caterina
    Salles, Gilles Andre
    Trneny, Marek
    de Vos, Sven
    Mir, Farheen
    Samineni, Divya
    Kim, Su Y.
    Jiang, Yanwen
    Punnoose, Elizabeth
    Sinha, Arijit
    Clark, Emma
    Spielewoy, Nathalie
    Humphrey, Kathryn
    Bazeos, Alexandra
    Zelenetz, Andrew D.
    BLOOD, 2021, 137 (05) : 600 - 609
  • [29] Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma
    Aslan, Alma
    Turker, Alev
    Kars, Ayse
    Barista, Ibrahim
    Ozdemir, Evren
    BLOOD, 2016, 128 (22)
  • [30] A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma
    Park, Steven I.
    Grover, Natalie S.
    Olajide, Oludamilola
    Asch, Adam S.
    Wall, James G.
    Richards, Kristy L.
    Sobol, Anna L.
    Deal, Allison M.
    Ivanova, Anastasia
    Foster, Matthew C.
    Muss, Hyman B.
    Shea, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 281 - 289
12345